TMEM30A
Cell cycle control protein 50A
Also known as: C6orf67, CC50A_HUMAN, CDC50A, FLJ10856
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NV96
- Gene
- TMEM30A
- Ensembl
- ENSG00000112697
- Chromosome
- 6
- Canonical length
- 361 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
Enables aminophospholipid flippase activity and structural molecule activity. Involved in several processes, including phospholipid transport; positive regulation of transport; and xenobiotic transmembrane transport. Located in endoplasmic reticulum; endosome membrane; and plasma membrane. Part of phospholipid-translocating ATPase complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
361 residues, UniProt reviewed canonical sequence.
>Q9NV96|TMEM30A
1 MAMNYNAKDE VDGGPPCAPG GTAKTRRPDN TAFKQQRLPA WQPILTAGTV LPIFFIIGLI
61 FIPIGIGIFV TSNNIREIEI DYTGTEPSSP CNKCLSPDVT PCFCTINFTL EKSFEGNVFM
121 YYGLSNFYQN HRRYVKSRDD SQLNGDSSAL LNPSKECEPY RRNEDKPIAP CGAIANSMFN
181 DTLELFLIGN DSYPIPIALK KKGIAWWTDK NVKFRNPPGG DNLEERFKGT TKPVNWLKPV
241 YMLDSDPDNN GFINEDFIVW MRTAALPTFR KLYRLIERKS DLHPTLPAGR YSLNVTYNYP
301 VHYFDGRKRM ILSTISWMGG KNPFLGIAYI AVGSISFLLG VVLLVINHKY RNSSNTADIT
361 ILocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEM30A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 97 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 97 nTPM
- liver: 93 nTPM
- parathyroid gland: 91 nTPM
- lung: 87 nTPM
- blood vessel: 85 nTPM
- thyroid gland: 79 nTPM
Single-cell type
- corticotrophs: 253 nCPM
- esophageal apical cells: 235 nCPM
- neutrophil progenitors: 198 nCPM
- neutrophils: 174 nCPM
- alveolar cells type 1: 147 nCPM
- pancreatic acinar cells: 146 nCPM
Immune cell
- neutrophil: 139 nTPM
- non-classical monocyte: 88 nTPM
- classical monocyte: 86 nTPM
- intermediate monocyte: 85 nTPM
- myeloid DC: 79 nTPM
- total PBMC: 62 nTPM
Brain region
- white matter: 155 nTPM
- hypothalamus: 137 nTPM
- spinal cord: 137 nTPM
- choroid plexus: 136 nTPM
- basal ganglia: 128 nTPM
- hippocampal formation: 123 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.77
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.06
- DepMap mean gene effect
- -0.17
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- aminophospholipid transport
- phospholipid translocation
- positive regulation of neuron projection development
- positive regulation of phospholipid translocation
- positive regulation of protein exit from endoplasmic reticulum
- protein localization to endosome
- xenobiotic transmembrane transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TMEM30A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEM30A as an antibody target. Whether an autoantibody or antibody against TMEM30A could matter depends on whether native TMEM30A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEM30A is annotated at the cell surface, where native TMEM30A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TMEM30A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...